Microbion has reported positive topline results from its Phase II study of pravibismane, a topical treatment for DFI.

The DACH region encompasses Germany, Austria, and Switzerland. Credit: Tom Korcak via Shutterstock. Amid tightening EU ...

At the 15mg dose, participants showed a sustained average weight loss of 22.9% during the three-year treatment. Credit: SB ...

The datapoint about BMD was discovered in a ‘hidden tab’ in Amgen’s data on Amgen’s Phase I trial MariTide data. Credits: Marlon Trottmann/Shutterstock.com Amgen has spoken out about concerns related ...

Despite this success, investors were unimpressed with the topline data, with Syndax’s stock dropping by 25.6%, from $21.78 ...

Medical advances and better knowledge of health have contributed to increased life expectancy and a growing elderly ...

They say lightning rarely strikes twice but Kezar Life Sciences has suffered its second clinical blow in as many months.

Lyophilization plays a crucial role in successful biologic molecule development, but what is lyophilization – and how can it ...

Longboard has commenced the Phase III DEEp OCEAN Study of bexicaserin for treating seizures linked to DEEs in two years and ...

The company plans to discontinue the study after the combination therapy failed to meet the primary endpoint in the Phase III ...

At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and ...

R327G is a topical gel treatment being analysed for diabetic foot infections. Credit: Olga Apanasenko/Shutterstock. Recce ...